Eiger BioPharmaceuticals Investor Relations Material
Latest events
Status Update
Eiger BioPharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Eiger BioPharmaceuticals Inc
Access all reports
Eiger BioPharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of targeted therapies for rare and ultra-rare diseases. The company’s therapeutic areas include infectious diseases, metabolic disorders, and genetic conditions. Eiger’s pipeline targets diseases with high unmet medical needs, and it works to bring new treatment options to patients who have limited alternatives. Its approach involves repurposing existing drugs and developing novel compounds to advance its treatment options through clinical trials and regulatory approvals. The company is headquartered in Palo Alto, California, and its shares are listed on the NASDAQ.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
EIGR
Country
🇺🇸 United States